Medline Inc. Class A Common Stock (MDLN) — Cash Flow Reinvestment Rate
Medline Inc. Class A Common Stock (MDLN) has a Cash Flow Reinvestment Rate of 0.23x as of March 2026, reinvesting $96.00 Million (capex $96.00 Million ) from operating cash flow of $412.00 Million. Check how high is Medline Inc. Class A Common Stock's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medline Inc. Class A Common Stock Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Medline Inc. Class A Common Stock across 4 annual periods. Explore MDLN operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Medline Inc. Class A Common Stock (2022–2025)
Year-by-year capital reinvestment analysis for Medline Inc. Class A Common Stock. For live market cap and broader valuation context, see MDLN stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | $447.00 Million | $1.74 Billion | $447.00 Million | ▲ +24.6% |
| 2024 | 0.21x | $364.00 Million | $1.77 Billion | $364.00 Million | ▲ +21.7% |
| 2023 | 0.17x | $285.00 Million | $1.69 Billion | $285.00 Million | ▼ -87.5% |
| 2022 | 1.36x | $254.00 Million | $187.00 Million | $254.00 Million | — |